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Susceptibility  of  IgGs  to oxidation  is  a signiﬁcant  issue  for intravenous  immunoglobulin  preparations
(IVIG)  in  liquid  solution  and  raises  both  safety  and  efﬁcacy  concerns.  Here  we  present  an  optimized  chro-
matography  method  coupled  to  mass  spectrometry  (MS)  to determine  the  oxidation  of  Fc/2  fragments
derived  from  polyclonal  IgGs  after  IdeS  treatment.  Separation  of  the  four IgG  subclasses  was  achievedeywords:
deS
ass spectrometry
VIG
xidation
using  a  diphenyl  column  and  UV/MS  detections  were  used  for quantiﬁcation  and  characterization.  Sev-
eral  oxidized  Fc/2  fragments  generated  by  stress  conditions  were  resolved  and  oxidized  methionines
were  identiﬁed.  This  procedure  can  be  used  to  monitor  the  oxidative  status  of IVIG  preparations  during
formulation  or  stability  studies.
© 2014  .  Published  by Elsevier  B.V. This  is an  open  access  article  under the  CC  BY-NC-ND  license
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. Introduction
Intravenous immunoglobulins (IVIG) are therapeutic products
hat contain pooled, polyvalent immunoglobulins G (IgGs) puriﬁed
rom the plasma of a large number of blood donors. IVIGs are used to
reat a number of autoimmune disorders, idiopathic diseases and
nfections. Chronic Inﬂammatory Demyelinating Polyneuropathy
CIDP), Immune Thrombocytopenic Purpura (ITP), Primary Immu-
odeﬁciency states and Secondary Immunodeﬁciency in Chronic
ymphocytic Leukemia account for approximately 70% of IVIG use,
ut given their broad spectrum of action, they can be used in numer-
us other indications [1,2]. New generation of IVIG products are
ow provided in a liquid formulation that is more easy-to-use
ompared to freeze-dried products. However, proteins in solution
re generally less stable and more susceptible to oxidation. This
odiﬁcation can lead to diverse functional consequences, such as
ecreased binding activities, increased aggregation and immuno-
enicity [3]. Oxidation reactions can be highly promoted by light
xposure [4]. According to regulatory requirements (ICHQ1B guide-
ine), photostability of a new active substance has to be investigated
nd oxidation appears as a relevant parameter. Peptide mapping,
Abbreviations: IVIG, intravenous immunoglobulin; IgG, immunoglobulin G; IdeS,
ysteine proteinase from Streptococcus pyogenes; PTMs, post-translational modiﬁ-
ations; Fc/2, constant fragment of IgG heavy chain; Fd, variable fragment of IgG
eavy chain; LC, light chain.
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570-0232/© 2014 . Published by Elsevier B.V. This is an open access article under the CC(http://creativecommons.org/licenses/by-nc-nd/3.0/).
commonly used to detect methionine oxidation [5], has never been
used for polyclonal IgGs due to the large degree of protein het-
erogeneity. Usually, the oxidative stress of polyclonal IgGs is only
addressed by measuring their carbonyl level and does not take into
account methionine oxidation.
In 2011, the use of a cysteine proteinase from Streptococcus pyo-
genes (IdeS) to characterize the sequence and post-translational
modiﬁcations (PTMs) of monoclonal antibodies has been reported
by Chevreux et al. [6]. This enzyme speciﬁcally cleaves human
IgG in the hinge region between the two glycines of the constant
sequence ELLGGPS [7]. After IgG reduction, this cleavage leads
to the release of the light chain (LC) and both variable (Fd) and
constant fragments of the heavy chain (Fc/2). Goetze et al. [8]
described the use of this approach to analyze polyclonal antibodies
in crude serum or after protein A treatment. In their studies, the
authors separated the Fc/2 of IgG1 and IgG2 by reverse phase chro-
matography and analyzed them by MS,  to obtain speciﬁc allotypic
composition and glycosylation information on the IgGs of various
patients.
Here, we describe an improved methodology to characterize the
oxidation state of puriﬁed polyclonal IgGs. The chromatographic
separation was optimized to increase resolution between IgG1 and
IgG2, to further discriminate their oxidized forms and to sepa-
rate the two minor IgG3 and IgG4 subclasses. MS  was  used to
identify each eluted species corresponding to the different IgG
subclasses and their allotypes. IVIG preparations submitted to pho-
tostability studies according to ICHQ1B guideline were analyzed
and for the ﬁrst time, methionine oxidation of polyclonal IgGs was
monitored.
 BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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with the theoretical masses of G1m17,1 (MTheo = 24,108 Da) and
G1m17,1,2 (MTheo = 24,094 Da) allotypes respectively [8,10]. The
second and third peaks of the chromatogram, eluted at 27.5 and
28.0 min  respectively, represent 31% of the total UV area, which is Y. Leblanc et al. / J. Ch
. Materials and methods
.1. Material
IVIG preparations were provided by LFB Biotechnologies from in
ouse batches developed for research purposes. MS  grade bovine
rypsin was obtained from Roche (Mannheim, Germany). The
deS endoprotease FabRICATOR and the IgGZERO glycosidase were
btained from Genovis (Lund, Sweden). Dithiothreitol (DTT) and
odoacetamide (IAA) were purchased from Sigma–Aldrich (Saint
uentin Fallavier, France). Vivapure Maxi A kit was obtained
rom Sartorius Stedim Biotech (Göttingen, Germany). Acetonitrile
MeCN) was HPLC grade reagent and purchased from JT Baker
Philipsburg, NJ, USA). Triﬂuoroacetic acid (TFA) was obtained from
erck Biosciences (Darmstadt, Germany). All the aqueous solutions
ere prepared using ultra-pure water (18.2 M cm resistivity at
5 ◦C, total organic carbon (TOC) < 5 ppb).
.2. Photo oxidative stress
Photo oxidized samples were obtained by submitting IVIG
reparations to light exposure at 250 W/m2 between 300 and
00 nm during 42 h, using the Atlas Suntest CPS+ system (Chicago,
L, USA).
.3. IgG4 enrichment by chromatofocusing
The chromatofocusing separation of IVIG was carried out on an
KTA Puriﬁer system equipped with a Mono P 5/200 GL column
GE Healthcare, Little Chalfont, UK). Elution was  achieved using
 gradient of solvent A (Diethanolamine 25 mM pH 9.5) and sol-
ent B (Polybuffer 96 1/10 pH 6.0) at a ﬂow rate of 1 ml/min. An
gG4 enriched fraction from elution between pH 6.1 and 6.4 was
ollected.
.4. IgG3 enrichment using protein A column
7 mg  of IVIG was diluted in a PBS solution pH 7.4 to a ﬁnal volume
f 10 ml  and centrifuged in a Vivapure Maxi A spin column at 100 g
or 30 min. The ﬂow through containing IgG3 was recycled seven
imes with this process for a complete removal of IgG1, IgG2 and
gG4.
.5. IgG fragmentation and reduction
Enzymatic proteolysis and glycolysis were achieved by incubat-
ng 10 l of sample at a concentration of 10 mg/ml in a phosphate
aline buffer with 100 UI of IdeS and 100 UI of IgGZero enzymes
or 1 h at 37 ◦C. Reduction of digested IgG was performed by adding
5 l of denaturation buffer (8 M Guanidine–HCl, Tris–HCl 0.1 M,
H 7.5) and 5 l of a 200 mM DTT solution. The preparation was
ncubated at 50 ◦C for 30 min.
.6. LC–MS analysis
Separation of the Fc/2 fragments was carried out on an Acquity
ystem (Waters, Milford, MA,  USA) coupled to a UV detector and an
lectrospray mass spectrometer (Synapt G2S, Waters, Milford, MA,
SA). Around 20 g of sample were injected on a Pursuit Diphenyl
50 mm × 2.0 mm column (Agilent, Santa Clara, CA, USA) equili-
rated at 70 ◦C and operated at a ﬂow rate of 200 l/min. An elution
radient was applied using solvent A (0.1% TFA in water) and sol-
ent B (90% MeCN, 10% water and 0.1% TFA), after an isocratic
lution at 10% B for 5 min, B was raised to 38% in 10 min  and to 44%
n an additional 48 min. The column was then washed for 4 min  at
0% of B and further equilibrated during 9 min  at 10% B. The massgr. B 961 (2014) 1–4
spectrometer was  operated in the positive resolution mode and
data were recorded from m/z 200 to 2000. Protein mass spectra
were deconvoluted using MassLynx software.
2.7. Peptide mapping
Trypsin digestion for peptide mapping was  performed follow-
ing common procedure. The obtained peptides were injected on
an Acclaim® PepMap100 C18 column (0.75 mm × 150 mm,  3 m)
using a U3000 nano-LC system ﬁtted with a preconcentration setup
and interfaced with a high resolution LTQ-Orbitrap mass spectrom-
eter (Thermoﬁscher Scientiﬁc, Bremen, Germany) operating in the
positive ion mode. The nanospray was  obtained with the appli-
cation of a 1.5-kV capillary voltage. The survey full scan MS  was
acquired in the Orbitrap analyzer at a resolving power of 30,000 (at
m/z 400) and using an automated gain control (AGC) target value set
to 1 × 106 charges whereas top ﬁve MS/MS  spectra were acquired
in the trap analyser using CID fragmentation mode and AGC target
value to 2 × 104 charges.
3. Results and discussion
3.1. Separation and identiﬁcation of Fc/2
Fc/2 fragments generated after IdeS treatment are the ﬁrst
eluted species in reverse phase chromatography due to their less
hydrophobic nature in comparison with the other IgG subunits
(LC and Fd). In order to maximize the chromatographic resolu-
tion between Fc/2 polypeptide chains, the gradient was performed
from 38% to 44% solvent B during an extended time of 48 min
while LC and Fd were eluted with the column ﬂush. A diphenyl
column was  used to take advantage of its improved selectivity com-
pared to conventional alkyl bonded phases as described by Ren
et al. [9]. In order to simplify mass spectra, all samples were deg-
lycosylated with an endoproteinase (IgGZero kit) that removes the
N-glycan antenna, leaving only a fucosylated GlcNAc, bound to the
polypeptide chain. Fig. 1 shows the UV chromatogram obtained
after the analysis of an IVIG preparation. Four major peaks are
observed, the ﬁrst one eluted at 24.7 min  represents 66% of the total
UV area, which is consistent with IgG1 abundance in plasma. The
deconvoluted mass spectrum of this peak shows a major mass at
24,140 Da that matches the theoretical mass (MTheo = 24,140 Da)
of the IgG1 allotype G1m3 (see Fig. 2A). Two minor masses at
24,108 Da and 24,094 Da are also observed and are in agreementFig. 1. Separation of Fc/2 fragments obtained after IdeS digestion and reduction of
IVIG using a diphenyl column.
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sig. 2. Deconvoluted mass spectra of IVIG Fc/2. Panels A to C represent mass spectra
f  IgG1 (A), IgG2 (B) and IgG3/IgG4 (C). Peaks are labeled with experimental average
olecular masses and corresponding allotypes.
onsistent with IgG2 abundance in plasma. The deconvoluted mass
pectrum of these two peaks shows masses of 24,142 and 24,174 Da
see Fig. 2B) that match the theoretical masses of the IgG2 allotypes
2m(n) (MTheo = 24,142 Da) and G2m(23) (MTheo = 24,174 Da),
espectively. The last peak observed in Fig. 1, eluted at 31.6 min
epresents 3% of the total UV area; this peak shows a major mass
t 24,160 Da and a minor one at 24,124 Da (see Fig. 2C). The mass
f 24,160 Da could correspond to the most common IgG3 allotype
3m5* considering a substitution of Tyr296 by Phe296 (Y296FEU
umbering) described as the most prevalent form in the French
opulation [11]. The secondary mass of 24,124 Da is consistent with
he Fc/2 theoretical mass (MTheo = 24,124 Da) of the unique IgG4
mino acid sequence described (see supplementary data). Fc/2 of
olyclonal IgG3 and IgG4 have never been investigated by MS.  We
ntended to conﬁrm their identiﬁcation by dedicated enrichment
teps of these two populations followed by LC–MS analysis.
.2. IgG3 and IgG4 identiﬁcation
Enrichment of IgG3 was carried out using a protein A spin
olumn, known to bind IgG3 with less efﬁcacy than the other
ubclasses. Fig. 3A displays the deconvoluted mass spectrum cor-
esponding to the enriched IgG3 sample with a major mass
f 24,160 Da. The chromatogram in insert shows a signiﬁcant
ncrease of the last peak (RT = 31.6 min). This result conﬁrms the
ttribution of the mass at 24,160 Da to the IgG3 subclass. To
onﬁrm the hypothesis of a Y296F mutation of the G3m5* allo-
ype, IgG3 were collected from the peak eluted at 31.6 min  and
nalyzed by nanoLC–MS/MS after trypsin digestion. The glyco-
ylated peptide [T289 KPREEQF296NSTFR301] was identiﬁed at aFig. 3. Deconvoluted mass spectra of Fc/2 IgG3 (A) and IgG4 (B). Inserts represent
Fc/2 chromatograms of enriched samples using a protein A spin column (A) and
chromatofocusing (B).
mass of 1987.9654 Da, hence conﬁrming the Y296F substitution
(Mtheo = 1987.9484). Additionally, speciﬁc peptides of the IgG3 allo-
type were retrieved in this experiment.
Next, IgG4 were enriched by chromatofocusing as they display
a lower isoelectric point than the other IgG subclasses. The more
acidic chromatofocusing fractions of IVIG have been analyzed on
the diphenyl column, results are displayed in Fig. 3B. The chro-
matogram in insert shows a signiﬁcant increase of the last peak
(RT = 31.6 min). Furthermore, a dramatic increase of the mass at
24,124 Da was  observed on the deconvoluted mass spectrum rela-
tively to Fig. 2C, hence conﬁrming the presence of IgG4 in this last
peak. As previously described, the peak eluted at 31.6 min was col-
lected and analyzed by peptide mapping and the identiﬁcation of
the IgG4 subclass was conﬁrmed. All these results allow complete
identiﬁcation of the different IgG subclasses and monitoring of their
oxidized forms during photostability studies.
3.3. Analysis of Fc/2 oxidation
The photostability of IVIG was  investigated according to regu-
latory requirements and oxidation was  monitored by the LC–MS
method described above. Fig. 4 displays the chromatogram of a
stressed IVIG sample. Three additional peaks are chromatograph-
ically resolved comparing to the native sample. The ﬁrst eluted
peak (RT = 22.5 min) presents a deconvoluted mass spectrum (see
Fig. 5A) with a major mass of 24,172 Da and two  minor masses of
24,140 and 24,126 Da. These masses display a mass shift of exactly
+32 Da compared to those observed for native IgG1 allotypes (see
Fig. 2A), this mass shift corresponds to doubly oxidized IgG1 allo-
types. The deconvoluted mass spectrum of the second eluted peak
(RT = 23.8 min) presents a more complex proﬁle with the presence
of oxidized forms belonging to both IgG1 and IgG2 subclasses (see
Fig. 5B). Indeed, masses at 24,156, 24,124 and 24,110 Da correspond
to the three IgG1 allotypes with a mass shift of +16 Da consistent
with a single oxidation. The mass at 24,222 Da corresponds to the
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2m(23) allotype with a mass shift of +48 Da consistent with three
xidations. The deconvoluted mass spectrum of the additional peak
bserved at RT = 26.5 min  is displayed in Fig. 5C. This mass spectrum
hows a major mass at 24,190 Da corresponding to the G2m(23)
llotype with a mass shift of +16 Da indicating one oxidation, the
xidized form of the G2m(n) allotype is also detected in lower abun-
ance at 24,158 Da. Finally, a thorough study of the deconvoluted
ass spectrum corresponding to the major peak (RT = 24.7 min)
ighlights two additional masses comparatively to the mass spec-
rum of native IgG1 allotypes (data not shown). These two masses of
ig. 5. Deconvoluted mass spectra of photo-oxidized IVIG Fc/2. Panels A to C repre-
ent mass spectra of oxidized IgG1 (A), oxidized IgG1/IgG2 (B) and oxidized IgG2 (C).
eaks are labeled with experimental average molecular masses and corresponding
xidized forms.
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24,206 and 24,174 Da correspond to the doubly oxidized IgG2 allo-
types. The co-elution of these IgG2 forms with non-modiﬁed IgG1
is consistent with the fact that mono- and triply oxidized forms of
IgG2 are eluted on both sides of the native IgG1 peak. Finally, the
elution of all the identiﬁed oxidized forms was also consistent with
their anticipated decrease of hydrophobicity following oxidation.
Monoclonal IgG oxidation is largely described in the literature;
indeed, the Fc region of antibodies is especially reported to contain
two solvent exposed methionines particularly sensitive to oxida-
tion: Met252 and Met428 [12–14]. In this study, all IgG1 allotypes
were detected with up to two  oxidations. Peptide mapping data
conﬁrmed oxidation of Met252 and Met428, including for the G1m3
allotype which contains an additional Met  in position 358 hence
indicating that Met358 was  non-oxidized (data not shown). This
result is in accordance with its buried position inside the Fc [13,14].
Considering IgG2 allotypes, G2m(n) contains four methionines on
its Fc/2 among which, up to two  oxidations were detected. G2m(23)
contains an additional methionine in position 282 and was
observed with up to three oxidations. As described in the literature
[13], Met252 and Met428 are preferentially oxidized for both G2m(n)
and G2m(23) and our results suggest that Met282 of G2m(23) is the
additional methionine susceptible to oxidation in this allotype.
4. Conclusion
In this study, we present a LC–MS method to monitor the oxida-
tion of polyclonal IgGs. IVIG preparations were submitted to IdeS
enzymatic proteolysis and Fc/2 were separated on a diphenyl col-
umn  and identiﬁed by MS.  The method was then used to precisely
monitor their methionine oxidation after photo-induced degrada-
tion. Signiﬁcant oxidation was  detected on IgG1 and IgG2 allotypes,
indicating that polyclonal IgGs are very sensitive to the light stress
described in the pharmacopeia. To our knowledge, this is the ﬁrst
time that such an approach to monitor oxidation of polyclonal IgGs
is described. This method should ﬁnd applications during formula-
tion and stability studies.
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